Dynamic left main coronary artery compression by a dilated pulmonary artery in a patient with pulmonary hypertension—a case report demonstrating the significance of multimodular imaging Authors: Julia S Lebbink, Matthijs Smits, Bas L van der Hoeven, Bastiaan E Schölzel, Jesse Habets, Raheel Ahmed, Marco Angelillis, John Kanakakis, Faris Kadíc Published: 2026 ABSTRACT AbstractBackgroundAlthough rare, dilation of the pulmonary artery, which can be present in patients with pulmonary arterial hypertension (PAH), can cause compression of the left main coronary artery (LMCA), leading to progressive dyspnoea, fatigue, syncope, and angina. Over time, this rare complication might lead to acute coronary syndrome.Case summaryA 63-year-old White female with a background of systemic hypertension and mild obstructive sleep apnoea was admitted to the emergency unit because of gradually worsening shortness of breath and generalized weakness, without associated anginal symptoms. Blood gas evaluation demonstrated impaired oxygenation, with a partial pressure of oxygen of 6.8 kPa and an oxygen saturation of 87.9%. Transthoracic echocardiography demonstrated marked right ventricular strain along with features consistent with pulmonary arterial hypertension. A CT pulmonary angiographic study showed pronounced enlargement of the pulmonary trunk, measuring 62 mm in diameter. Subsequent coronary angiography combined with intravascular ultrasound identified greater than 50% narrowing of the left main coronary artery due to extrinsic compression, which was corroborated by dynamic CT imaging. The patient underwent IVUS-guided percutaneous revascularization of the left main coronary artery with placement of a drug-eluting stent. One week post-discharge, prior to additional diagnostic evaluation and management of pulmonary arterial hypertension, the patient reported significant symptomatic relief, with functional status improving from New York Heart Association (NYHA) class III to class II.DiscussionThis case underscores that extrinsic compression of the LMCA due to pulmonary artery dilatation warrants consideration as a potential aetiology of symptoms, even in the absence of angina.Keywords: Pulmonary hypertension, Percutaneous coronary intervention, Pulmonary artery dilatation, Left main coronary artery, Case report In patients with dilated pulmonary arteries exceeding 40 mm, screening for LMCA compression should be considered, even in the absence of angina-like symptoms. In patients with dilated pulmonary arteries exceeding 40 mm, screening for LMCA compression should be considered, even in the absence of angina-like symptoms. Multimodality imaging with dynamic CTA and IVUS should be considered when there is a discrepancy between coronary anatomy and symptoms. Multimodality imaging with dynamic CTA and IVUS should be considered when there is a discrepancy between coronary anatomy and symptoms. Introduction Pulmonary hypertension (PH) is a progressive and multifactorial haemodynamic disorder defined by a mean pulmonary arterial pressure (mPAP) ≥ 20 mmHg at rest, as established by right heart catheterization (RHC).1 Dilatation of the main pulmonary artery (PA) is frequently observed in patients with PH and correlates strongly with the mPAP.2 A common symptom in patients with PH is chest pain, occurring in over 40% of cases.3 Extrinsic compression of the LMCA by a dilated PA represents a rare yet potentially fatal complication of PH, which may precipitate angina, syncope, or even myocardial infarction.4 Accurate diagnosis using coronary angiography alone is challenging due to the dynamic nature of the lesion and the external compressive aetiology, which may not be fully appreciated. Summary figure Case presentation A 63-year-old White woman with a medical history of stroke, hypertension, mild obstructive sleep apnoea, and obesity presented with progressive dyspnoea [New York Heart Association (NYHA) class III]. There were no clinical signs of decompensated heart failure. Electrocardiography (Figure 1) showed right axis deviation, prominent P-waves, and diffuse T-wave abnormalities. Laboratory testing was unremarkable except for elevated D-dimer levels. Electrocardiogram showing right axis deviation and prominent p-waves, as well as diffuse T-wave abnormalities. Transthoracic echocardiography demonstrated severe right ventricular overload with a D-shaped interventricular septum and an estimated systolic pulmonary arterial pressure of 87 mmHg. Left ventricular systolic and diastolic function were normal, and significant valvular disease was excluded. Arterial blood gas analysis revealed hypoxemia with a partial pressure of oxygen of 6.8 kPa and an oxygen saturation of 87.9%. The patient was referred to the emergency department to exclude pulmonary embolism. Computed tomography (CT) pulmonary angiography showed severe dilatation of the main pulmonary artery (6.2 cm) without evidence of acute or chronic pulmonary embolism, pneumonia, decompensated heart failure, or other diseases that could explain the progressive dyspnoea. Symptoms were therefore attributed to the exacerbation of pulmonary hypertension. Treatment with a loop diuretic was initiated, and the patient was discharged in stable condition with referral for RHC to further investigate the aetiology of PH. As no definitive diagnosis had yet been established, no PAH–specific medication had been initiated yet. RHC, performed in a euvolemic state, demonstrated an mPAP of 52 mmHg. Pulmonary capillary wedge pressure and left ventricular end-diastolic pressure were both 12 mmHg, and oxygen saturation measurements showed no evidence of intracardiac shunting, excluding left-sided heart disease as the cause of PH. Subsequently, because of the patient’s cardiovascular risk profile (active smoker, dyslipidaemia, and obesity), repolarization abnormalities, and coronary calcifications on CT, coronary angiography was performed and revealed significant luminal narrowing of the LMCA ostium (Figure 2). Additional imaging with intravascular ultrasound (IVUS) was conducted, which demonstrated external compression of the LMCA resulting in a luminal diameter reduction exceeding 50% (MLA during diastole 7.9 mm2 and during systole 3.2 mm2) without additional evidence of significant atherosclerotic coronary artery disease (Supplementary material online, Video S1 and Figure 3). Optimal stent position, apposition, and expansion were confirmed with repeat IVUS. A dynamic coronary CT angiogram (Supplementary material online, Video S2) confirmed the findings of the CAG, and after consultation with the national expertise centre for pulmonary hypertension, IVUS-guided percutaneous coronary intervention of the LMCA was performed with implantation of a drug-eluting stent. Coronary angiogram revealing ostial left main coronary artery stenosis. IVUS demonstrating 59% dynamic external compression of the LMCA. During diastole, eccentricity of the lumen can already be appreciated, indicating some compression of the LMCA during diastole. During systole, this compression increases severely, leading to significant narrowing of the LMCA. LMCA during diastole (3A: minimum lumen area 7,9 mm2), and during systole (3B: minimum lumen area 3.2 mm2). The patient was discharged the following day and referred to a specialty centre for further diagnostic evaluation to ascertain the aetiology of the PH. One-week post-discharge, while still undergoing assessment and prior to initiation of PAH-specific therapy, the patient reported amelioration in her clinical condition and dyspnoea with NYHA class improving from III to II. Significantly, the patient consistently denied experiencing chest pain or symptoms resembling angina. Idiopathic PAH was later diagnosed, and treatment with ambrisentan and tadalafil was initiated. Follow-up echocardiography and RHC demonstrated a reduction in pulmonary arterial pressure from 52 to 46 mmHg, however, accompanied by little clinical improvement. Clinical follow-up will consist of outpatient clinic visits, follow-up echocardiography, and CT. Discussion LMCA compression is an uncommon complication of pulmonary hypertension, occurring in approximately 6% of patients with PAH, but in up to 40% of those presenting with angina.5 Chronic elevation of pulmonary arterial pressure results in sustained haemodynamic overload and maladaptive vascular remodelling. Increased circumferential wall stress promotes outward remodelling of the proximal PA, while structural changes such as medial hypertrophy, elastin fragmentation, and collagen deposition reduce arterial compliance and facilitate progressive dilatation.6 Inflammatory and immune-mediated pathways further promote smooth muscle proliferation and extracellular matrix turnover, destabilizing the arterial wall.6,7 Progressive stiffening of the proximal PA increases pulsatile load and wall tension, establishing a self-reinforcing cycle of stiffening and dilatation.7, 8 In advanced disease, right ventricular–pulmonary arterial uncoupling increases flow pulsatility and shear stress, contributing to proximal PA enlargement.7,8 An enlarged PA can exert mechanical compression on the left main coronary artery (LMCA). This can result in myocardial ischaemia, biventricular dysfunction, or sudden cardiac death if unrecognized.9 The proximal LMCA courses between the aortic root and main PA; PA dilatation can compress the LMCA against the relatively rigid aorta, particularly when PA diameter exceeds a certain threshold (commonly cited >40–45 mm).10 Predisposing anatomical features include a high or anterior LMCA take-off, a narrow aortopulmonary angle, and a long, relatively immobile LMCA trunk.11,12 Elevated PA pressures and increased pulsatility can produce a dynamic, systolic component of compression that worsens with exercise, tachycardia, or increased right ventricular output.13 As referenced in the European Society of Cardiology (ESC) guidelines for the diagnosis and management of pulmonary hypertension, percutaneous coronary intervention (PCI) in patients with left main coronary artery compression is deemed an effective and safe therapeutic approach, notwithstanding the absence of a formal recommendation.1 Prior studies have shown that PCI can result in rapid symptomatic improvement with favourable long-term outcomes.5 IVUS plays a crucial role in diagnosing LMCA compression and guiding intervention by allowing accurate assessment of dynamic extrinsic narrowing and stent optimization.4,14 In a meta-analysis conducted by Badea et al., a pulmonary artery diameter exceeding 40 mm was correlated with left main coronary artery (LMCA) compression, prompting a recommendation for screening for LMCA compression in patients with pulmonary artery diameters ranging from 40 to 44 mm.10 In the present case, the PA measured 62 mm, and despite the absence of angina, PCI resulted in substantial symptomatic improvement. This highlights the importance of considering LMCA compression as a cause of symptoms in patients with marked PA dilatation, even when anginal complaints are absent. Additionally, LMCA compression may increase the risk of sudden cardiac death in patients with PAH due to the high prevalence of malignant arrhythmias in this population.15 This underscores the importance of multimodal imaging, particularly IVUS, for accurate diagnosis and integrated management of both coronary and pulmonary pathologies for effective long-term care. Conclusion Compression of the left main coronary artery due to pulmonary artery dilatation is a rare complication of pulmonary hypertension. This case underscores that extrinsic compression of the LMCA due to pulmonary artery dilatation warrants consideration as a potential aetiology of symptoms, even in the absence of angina. Screening for LMCA compression should be contemplated in patients exhibiting pulmonary artery dilatation exceeding 40 mm. Supplementary Material Contributor Information Julia S Lebbink, Department of Cardiology, Haaglanden Medical Center, Lijnbaan 32, 2512VA The Hague, The Netherlands. Matthijs Smits, Department of Cardiology, Haaglanden Medical Center, Lijnbaan 32, 2512VA The Hague, The Netherlands. Bas L van der Hoeven, Department of Cardiology, Haaglanden Medical Center, Lijnbaan 32, 2512VA The Hague, The Netherlands. Bastiaan E Schölzel, Department of Cardiology, Haaglanden Medical Center, Lijnbaan 32, 2512VA The Hague, The Netherlands. Jesse Habets, Department of Radiology & Nuclear Medicine, Haaglanden Medical Center, Lijnbaan 32, 2512VA The Hague, The Netherlands; Department of Radiology, St Antonius Hospital, Koekoekslaan 1, 3435CM Nieuwegein, The Netherlands. Lead author biography For image description, please refer to the figure legend and surrounding text. J. S. Lebbink, MD, obtained her medical degree from Leiden University in 2023. She subsequently completed a year of clinical practice in pulmonology before joining the cardiology department, where she currently works as a junior physician. Her professional interests include cardiovascular and pulmonary physiology. Supplementary material Supplementary material is available at European Heart Journal – Case Reports online. Consent: The author/s confirm that written consent for submission and publication of this case report including image(s) and associated text has been obtained from the patient. Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Publication costs were supported by Haaglanden Medical Center. Data availability The data underlying this article will be shared on reasonable request to the corresponding author. References Associated Data Supplementary Materials Data Availability Statement The data underlying this article will be shared on reasonable request to the corresponding author.